Abstract
Objective
This article addresses the state of the art concerning the treatment of binge eating disorder (BED). Pharmacological and psychotherapeutic strategies, together with issues concerning the involvement in bariatric surgery are considered.
Method
A Medline enquiry of published articles was performed using the following keywords: BED, pharmacological treatment, duloxetine, venlafaxine, SSRI, psychotherapy, bariatric surgery; reviews and single-case studies were also analyzed.
Results
Psychological interventions that have shown efficacy in the treatment of Bulimia Nervosa have also been tested in BED with positive results, in particular modified cognitive behavioral therapy, interpersonal therapy and dialectical behavior therapy. In addition pharmacotherapy with SSRIs is successful in transiently reducing binge-eating and body weight; the SNRI duloxetine is effective for reducing binge eating, and global severity of illness with a controversial effect on body weight; both topiramate and sibutramine seem promising, but their use is restricted due to labeling and side effect limitations, respectively. Finally, adequate psychological/pharmacological support can help BED patients obtain positive outcomes from bariatric surgery.
Conclusion
Studies on BED treatment are burdened by several limitations as selection biases (e.g. mostly women and overweight), small samples, high drop-out rates and placebo response.
Similar content being viewed by others
References
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Press, Washington
Wilfley DE, Bishop ME, Wilson GT et al (2007) Classification of eating disorders: toward DSM-V. Int J Eat Disord 40(Suppl):S123–S129
Spitzer RL, Devlin M, Walsh TB et al (1992) Binge eating disorder: a multisite field trial of the diagnostic criteria. Int J Eat Disord 11:191–203
Telch CF, Agras WS, Rossiter EM (1988) Binge eating increases with increasing adiposity. Int J Eat Disord 7:115–119
Yanovski SZ (1993) Binge eating disorder: current knowledge and future directions. Obes Res 1:06–324
De Zwaan M, Mitchell JE, Raymond NC et al (1994) Binge eating disorder: clinical features and treatment of a new diagnosis. Harv Rev Psychiatry 1:310–325
Ramacciotti CE, Coli E, Passaglia C et al (2000) Binge eating disorder: prevalence and psychopathological features in a clinical sample of obese people in Italy. Psychiatry Res 94(2):131–138
Wade TD, Lowes J (2002) Variables associated with disturbed eating habits and overvalued ideas about the personal implications of body shape and weight in a female adolescent population. Int J Eat Disord 32:39–45
Masheb RM, Grilo CM (2003) The nature of body image disturbance in patients with binge eating disorder. Int J Eat Disord 33:333–341
Stein KF, Corte C (2003) Reconceptualizing causative factors and intervention strategies in the eating disorders: a shift from body image to self-concept impairments. Arch Psychiatr Nurs 17:57–66
Jacobi C, Paul T, De Zwaan M et al (2004) Specificity of self-concept disturbances in eating disorders. Int J Eat Disord 35:204–210
Ramacciotti CE, Coli E, Bondi E et al (2008) Shared psychopathology in obese subjects with and without binge-eating disorder. Int J Eat Disord 41(7):643–649
Mitchell JE, Mussel M (1995) Comorbidity and binge eating disorder. Addict Behav 20(6):725–732
Simon GE, Von Korff M, Saunders K et al (2006) Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry 63:824–830
Marcus MD (1995) Binge eating and obesity. In: Brownell KD, Fairburn CG (eds) Eating disorders and obesity: a comprehensive handbook. Guilford, New York, pp 441–444
Ramacciotti CE, Paoli RA, Marcacci G et al (2005) Relationship between bipolar illness and binge-eating disorders. Psychiatry Res 135:165–170
National Institute of Health (1998) Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults: the evidence report
Abell CA, Farquhar DL, Galloway S McL et al (1986) Placebo controlled double-blind trial of fluvoxamine maleate in the obese. J Psychosom Res 30:143–146
Marcus MD, Wing RR, Ewing L et al (1990) A double-blind, placebo-controlled trial of fluoxetine plus behaviour modification in the treatment of obese binge-eaters and non-binge-eaters. Am J Psychiatry 147:876–881
Nutsinger DO, de Zwaan M, Schonbeck G et al. (1988) Controlled trial of fluvoxamine and behaviour therapy in the treatment of depressed obese. In: Poster presented at the XVI CINP Congress, Munich, 15–17 August 1988
Marcus MD (1997) Adapting treatment for patients with binge eating disorder. In: Garner DM, Garfinkel PE (eds) Handbook of treatment for eating disorders. Guilford Press, New York, pp 484–493
Byrne SM, McLean NJ (2002) The cognitive-behavioral model of Bulimia nervosa. A direct evaluation. Int J Eat Disord 31:17–31
Byrne SM (2002) Psychological aspects of weight maintenance and relapse in obesity. J Psychosom Res 53:1029–1036
Byrne S, Cooper Z, Fairburn C (2003) Weight maintenance and relapse in obesity: a qualitative study. Int J Obes Relat Metab Disord 27:955–962
Byrne SM, Cooper Z, Fairburn CG (2004) Psychological predictors of weight regain in obesity. Behav Res Ther 42:1341–1356
Yanovski SZ, Sebring NG (1994) Recorded food intake of obese women with binge eating disorder before and after weight loss. Int J Eat Disord 15:135–150
Downe KA, Goldfein JA, Devlin MJ (2009) Restraint, hunger, and disinhibition following treatment for binge-eating disorder. Int J Eat Disord 42:498–504
Schulz S, Laessle RG (2010) Associations of negative affect and eating behaviour in obese women with and without binge eating disorder. Eat Weight Disord 15:e287–e293
Barry DT, Grilo CM, Masheb RM (2003) Comparison of patients with bulimia nervosa, obese patients with binge eating disorder, and non obese patients with binge eating disorder. J Nerv Ment Dis 191:589–594
Ramacciotti CE, Dell’Osso L, Paoli RA et al (2002) Characteristics of eating disorder patients without a drive for thinness. Int J Eat Disord 32:206–212
Brownley KA, Berkman ND, Sedway JA et al (2007) Binge eating disorder treatment: a systematic review of randomized controlled trials. Int J Eat Disord 40:337–348
Bulik CM, Brownley KA, Shapiro JR (2007) Diagnosis and management of binge eating disorder. World Psychiatry 6:142–148
Reas DL, Grilo CM (2008) Review and meta-analysis of pharmacotherapy for binge-eating disorder. Obesity (Silver Spring) 16:2024–2038
Aigner M, Treasure J, Kaye W et al (2011) World federation of societies of biological psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders. World J Biol Psychiatry 12:400–443
Laederach-Hofmann K, Graf C, Horber F et al (1999) Imipramine and diet counselling with psychological support in the treatment of obese binge eaters: a randomized, placebo-controlled double-blind study. Int J Eat Disord 26:231–244
Calandra C, Russo RG, Luca M (2011) Bupropion versus sertraline in the treatment of depressive patients with binge eating disorder: retrospective cohort study. Psychiatr Q 83:177–185
Leombruni P, Lavagnino L, Gastaldi F et al (2009) Duloxetine in obese binge eater outpatients: preliminary results from a 12-week open trial. Hum Psychopharmacol 24:483–488
Guerdjikova AI, McElroy SL, Winstanley EL et al. (2011) Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial. Int J Eat Disord 45:281–289
Malhotra S, King KH, Welge JA et al (2002) Venlafaxine treatment of binge-eating disorder associated with obesity: a series of 35 patients. J Clin Psychiatry 63:802–806
Leombruni P, Lavagnino L, Fassino S (2009) Treatment of obese patients with binge eating disorder using topiramate: a review. Neuropsychiatr Dis Treat 5:385–392
Marazziti D, Rossi L, Baroni S et al. (2011) Novel treatment options of binge eating disorder. Curr Med Chem 18:5159–5164
McElroy SL, Kotwal R, Guerdjikova AI et al (2006) Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial. J Clin Psychiatry 67:1897–1906 (erratum in J Clin Psychiatry 2007 68:172)
Ricca V, Castellini G, Lo Sauro C et al (2009) Zonisamide combined with cognitive behavioral therapy in binge eating disorder: a one-year follow-up study. Psychiatry (Edgmont) 6:23–28
Guerdjikova AI, McElroy SL, Welge JA et al (2009) Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial. Int Clin Psychopharmacol 24(3):150–158
McElroy SL, Guerdjikova AI, Winstanley EL et al (2011) Acamprosate in the treatment of binge eating disorder: a placebo-controlled trial. Int J Eat Disord 44:81–90
McElroy SL, Guerdjikova AI, Winstanley EL et al (2011) Sodium oxybate in the treatment of binge eating disorder: an open-label, prospective study. Int J Eat Disord 44:262–268
Drewnowski A, Krahn DD, Demitrack MA et al (1995) Naloxone, an opiate blocker, reduces the consumption of sweet high-fat foods in obese and lean female binge eaters. Am J Clin Nutr 61:1206–1212
Appolinario JC, Bacaltchuk J, Sichieri R et al (2003) A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder. Arch Gen Psychiatry 60:1109–1116
Tziomalos K, Krassas GE, Tzotzas T (2009) The use of sibutramine in the management of obesity and related disorders: an update. Vasc Health Risk Manag 5:441–452
Coutinho W (2009) The first decade of sibutramine and orlistat: a reappraisal of their expanding roles in the treatment of obesity and associated conditions. Arq Bras Endocrinol Metabol 53:262–270
Wilfley DE, Welch RR, Stein RI et al (2002) A randomized comparison of group cognitive behavioral therapy and group interpersonal therapy for the treatment of overweight individuals with binge-eating disorder. Arch Gen Psychiatry 59:713–721
Hilbert A, Tuschen-Caffier B (2004) Body image interventions in cognitive-behavioral therapy of binge-eating disorder: a component analysis. Behav Res Ther 42:1325–1329
Devlin MJ, Goldfein JA, Petkova E et al (2005) Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder. Obes Res 13:1077–1088
Vocks S, Tuschen-Caffier B, Pietrowski R et al (2010) Meta-analysis of the effectiveness of psychological and pharmacological treatments for binge eating disorder. Int J Eat Disord 43:205–217
Telch CF, Agras WS, Linehan MM (2001) Dialectical behavior therapy for binge eating disorder. J Consult Clin Psychol 69:1061–1065
Robinson AH, Safer DL (2011) Moderators of dialectical behavior therapy for binge eating disorder: results from a randomized controlled trial. Int J Eat Disord
Grilo CM, Masheb RM, Wilson GT et al (2011) Cognitive-behavioral therapy, behavioral weight loss, and sequential treatment for obese patients with binge-eating disorder: a randomized controlled trial. J Consult Clin Psychol 79:675–685
Grilo CM, White MA, Wilson GT et al (2011) Rapid response predicts 12-month post-treatment outcomes in binge-eating disorder: theoretical and clinical implications. Psychol Med 16:1–11
Safer DL, Joyce EE (2011) Does rapid response to two group psychotherapies for binge eating disorder predict abstinence? Behav Res Ther 49:339–345
Sysko R, Hildebrandt T, Wilson GT et al (2010) Heterogeneity moderates treatment response among patients with binge eating disorder. J Consult Clin Psychol 78:681–690
Crow SJ (2003) Group interpersonal psychotherapy may be as effective as group cognitive behavioural therapy for overweight people with binge eating disorder. Evidence Based Ment Health 6:56
Neumark-Sztainer D, Wall M, Story M et al (2009) Five-year longitudinal predictive factors for disordered eating in a population-based sample of overweight adolescents: implications for prevention and treatment. Int J Eat Disord 42:664–672
Wildes JE, Marcus MD, Kalarchian MA et al (2010) Self-reported binge eating in severe pediatric obesity: impact on weight change in a randomized controlled trial of family-based treatment. Int J Obes (Lond) 34:1143–1148
Hsu LK, Mulliken B, McDonagh B et al (2002) Binge eating disorder in extreme obesity. Int J Obes Relat Metab Disord 26:1398–1403
Livhits M, Mercado C, Yermilov I et al. (2011) Preoperative predictors of weight loss following bariatric surgery: systematic review. Obes Surg 22:70–89
Sansone RA, Schumacher D, Wiederman MW (2008) The prevalence of binge eating disorder and borderline personality symptomatology among gastric surgery patients. Eat Behav 9:197–202
Jones-Corneille LR, Wadden TA, Sarwer DB et al. (2010) Axis I psychopathology in bariatric surgery candidates with and without binge eating disorder: results of structured clinical interviews. Obes Surg 22:389–397
Wadden TA, Faulconbridge LF, Jones-Corneille LR et al (2011) Binge eating disorder and the outcome of bariatric surgery at one year: a prospective, observational study. Obesity 19:1220–1228
Allison KC, Wadden TA, Sarwer DB et al (2006) Night eating syndrome and binge eating disorder among persons seeking bariatric surgery: prevalence and related features. Obesity 6(2):153–158
White MA, Masheb RM, Rothschild BS et al (2006) The prognostic significance of regular binge eating in extremely obese gastric bypass patients: 12-month postoperative outcomes. J Clin Psychiatry 67:1928–1935
Sallet PC, Sallet JA, Dixon JB et al (2007) Eating behavior as a prognostic factor for weight loss after gastric bypass. Obes Surg 17:445–451
Colles SL, Dixon JB, O’Brien PE (2008) Grazing and loss of control related to eating: two high-risk factors following bariatric surgery. Obesity 16:615–622
Dahl JK, Eriksen L, Vedul-Kjelsås E et al (2010) Prevalence of all relevant eating disorders in patients waiting for bariatric surgery: a comparison between patients with and without eating disorders. Eat Weight Disord 15:e247–e255
Busetto L, Segato G, De Luca M et al (2005) Weight loss and postoperative complications in morbidly obese patients with binge eating disorder treated by laparoscopic adjustable gastric banding. Obes Surg 15:195–201
Scholtz S, Bidlake L, Morgan J et al (2007) Long-term outcomes following laparoscopic adjustable gastric banding: postoperative psychological sequelae predict outcome at 5-year follow-up. Obes Surg 17:1220–1225
Ashton K, Drerup M, Windover A et al (2009) Brief, four-session group CBT reduces binge eating behaviors among bariatric surgery candidates. Surg Obes Relat Dis 5:257–262
Ashton K, Heinberg L, Windover A et al (2011) Positive response to binge eating intervention enhances postoperative weight loss. Surg Obes Relat Dis 7:315–320
Dolfing JG, Wolffenbuttel BH, ten Hoor-Aukema NM et al (2005) Daily high doses of fluoxetine for weight loss and improvement in lifestyle before bariatric surgery. Obes Surg 15:1185–1191
Rzehak P, Meisinger C, Woelke G et al (2007) Weight change, weight cycling and mortality in the ERFORT male cohort study. Eur J Epidemiol 22:665–673
Treasure J, Claudino AM, Zucker N (2010) Eating disorders. Lancet 375:583–593
Guerdjikova AI, McElroy SL (2009) Binge eating disorder pharmacotherapy clinical trials-who is left out? Eur Eat Disord Rev 17:101–108
Mukamal KJ, Miller M (2010) Invited commentary: body mass index and suicide-untangling an unlikely association. Am J Epidemiol 172:900–904 (discussion 905–906)
Omalu BI, Cho P, Shakir AM et al (2005) Suicides following bariatric surgery for the treatment of obesity. Surg Obes Relat Dis 1:447–449
Tindle HA, Omalu B, Courcoulas A et al (2010) Risk of suicide after long-term follow-up from bariatric surgery. Am J Med 123:1036–1042
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ramacciotti, C.E., Coli, E., Marazziti, D. et al. Therapeutic options for binge eating disorder. Eat Weight Disord 18, 3–9 (2013). https://doi.org/10.1007/s40519-013-0003-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40519-013-0003-5